Abstract: The present invention relates generally to the field of ocular therapeutics and the development thereof for use in humans or animals. More particularly, it relates to DHODH inhibitor compounds and their use for the treatment of ophthalmic diseases and disorders. The invention also relates to the local administration of such ophthalmic compositions, and in particular to their intravitreal administration. The invention relates also to controlled release formulations of therapeutically active agents, in particular of DHODH inhibitor compounds administered intraocularly, in particular in the posterior segment of the eye.

Abstract: The present invention relates generally to the field of ocular therapeutics and the development thereof for use in humans or animals. More particularly, it relates to DHODH inhibitor compounds and their use for the treatment of ophthalmic diseases and disorders. The invention also relates to the local administration of such ophthalmic compositions, and in particular to their intravitreal administration. The invention relates also to controlled release formulations of therapeutically active agents, in particular of DHODH inhibitor compounds administered intraocularly, in particular in the posterior segment of the eye.

Abstract: The present invention provides an ophthalmic composition comprising an active pharmaceutically compound non-covalently bound to albumin. The composition of the present invention is useful for treatment of ophthalmic diseases and disorders.

Abstract: The invention is related to a smart testing apparatus and preferably a method for testing at least a first DUT and a second DUT using a mobile communications testing device. The method comprises the steps of determining, whether a first RF test signal from/to the first DUT interferes with a second RF test signal from/to the second DUT. It determines, whether the second RF test signal from/to second DUT interferes with the first RF test signal from/to the first DUT. It predetermines, whether at least measuring the first measuring result obtained by applying the first RF test signal is disturbed above a first disturbance threshold value. It predetermines, whether at least a second measuring result obtained by applying the second RF test signal is disturbed above a second disturbance threshold value.

Abstract: A test system for testing a plurality of devices under test (DUTs) is provided. The test system comprises a test signal generator configured to generate test signals to be transmitted to the DUTs, wherein the test signals comprise at least one synchronization signal. The test signal generator is configured to broadcast the at least one synchronization signal to the DUTs. It is thereby possible to simultaneously test more than one DUT.

Abstract: The present invention relates to a calibration method and a calibration arrangement for a RF test apparatus for testing a RF device under test. Instead, a calibration board is provided and connected to each of the cables of the RF test apparatus. A calibration board is configured to provide a plurality of connection loops by connecting the input/output channel terminals of the test apparatus one after the other with each other. This results to a bunch of different connection loops. Then a physical parameter, such as the attenuation over frequency, is measured for each of these connection loops. Since each physical parameter can be described by a single equation, this results to an amount of different equations which form an equation system. The idea underlying the present invention is that the amount of equations of this equation system, which amount corresponds to the different connection loops, is at least equal or higher than the amount of unknown parameters of the equation system.

Abstract: The invention is related to a smart testing apparatus and preferably a method for testing at least a first DUT and a second DUT using a mobile communications testing device. The method comprises the steps of determining, whether a first RF test signal from/to the first DUT interferes with a second RF test signal from/to the second DUT. It determines, whether the second RF test signal from/to second DUT interferes with the first RF test signal from/to the first DUT. It predetermines, whether at least measuring the first measuring result obtained by applying the first RF test signal is disturbed above a first disturbance threshold value. It predetermines, whether at least a second measuring result obtained by applying the second RF test signal is disturbed above a second disturbance threshold value.

Abstract: A test system for testing a plurality of devices under test (DUTs) is provided. The test system comprises a test signal generator configured to generate test signals to be transmitted to the DUTs, wherein the test signals comprise at least one synchronization signal. The test signal generator is configured to broadcast the at least one synchronization signal to the DUTs. It is thereby possible to simultaneously test more than one DUT.

Abstract: The present invention relates generally to the field of ocular therapeutics and the development thereof for use in humans or animals. More particularly, it relates to DHODH inhibitor compounds and their use for the treatment of ophthalmic diseases and disorders. The invention also relates to the local administration of such ophthalmic compositions, and in particular to their intravitreal administration. The invention relates also to controlled release formulations of therapeutically active agents, in particular of DHODH inhibitor compounds administered intraocularly, in particular in the posterior segment of the eye.

Abstract: The present invention relates to a calibration method and a calibration arrangement for a RF test apparatus for testing a RF device under test. Instead, a calibration board is provided and connected to each of the cables of the RF test apparatus. A calibration board is configured to provide a plurality of connection loops by connecting the input/output channel terminals of the test apparatus one after the other with each other. This results to a bunch of different connection loops. Then a physical parameter, such as the attenuation over frequency, is measured for each of these connection loops. Since each physical parameter can be described by a single equation, this results to an amount of different equations which form an equation system. The idea underlying the present invention is that the amount of equations of this equation system, which amount corresponds to the different connection loops, is at least equal or higher than the amount of unknown parameters of the equation system.

Abstract: The present invention describes a method or uses of prevention and/or treatment of a cancer or a tumor, and in particular to a combination therapy, methods, compositions and pharmaceutical packages comprising an inhibitor of receptors of the EGFR family or a chemotherapeutically active pyrimidine analogue and certain platinum-based chemotherapeutic agents.

Abstract: The present invention describes a method or uses of prevention and/or treatment of a cancer or a tumor, and in particular to a combination therapy, methods, compositions and pharmaceutical packages comprising an inhibitor of receptors of the EGFR family or a chemotherapeutically active pyrimidine analogue and certain platinum-based chemotherapeutic agents.